Detection Kit for Monkeypox Virus ( Real-time PCR )

Detection Kit for Monkeypox Virus ( Real-time PCR ) is designed for the qualitative detection of Monkeypox Virus (MPV) DNA extracted from skin, fluid, or crusts collected directly from skin lesions. It's based on real-time PCR technology, the primers and probes target specific sequences of MPV, and do not react with nucleic acids of other pathogens.

MPV Ag Rapid Test

The MPV Ag Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of Monkeypox Virus (MPV) Antigen in human serum, oropharyngeal, skin lesion samples (skin surface and / or exudate swabs).

MPV IgG/IgM Rapid Test

The MPV IgG/IgM Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection and differentiation of IgM and IgG antibodies to Monkeypox Virus (MPV) in human serum, plasma, venous whole blood, or fingertip blood. It is intended for use as an aid in identifying individuals with an adaptive immune response to MPV, indicating recent or prior infection. At this time, it is unknown how long antibodies persist following infection and if the presence of antibodies confers protective immunity. The MPV IgG/IgM Rapid Test should not be used to diagnose acute MPV infection. For professional in vitro diagnostic use only.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

ST2 Rapid Quantitative Test

ST2 is a member of the interleukin-1 receptor family biomarker and circulating soluble ST2 concentrations are believed to reflect cardiovascular stress and fibrosis. The studies have demonstrated soluble ST2 to be a strong predictor of cardiovascular outcomes in both chronic and acute heart failure. It is a new biomarker that meets all required criteria for a useful biomarker.

HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)

HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Glycated hemoglobin A1c (HbA1c) concentration in human whole blood that contains EDTA or without anticoagulants samples, mainly used for the supervising of long-term glycemic control in diabetic individuals and auxiliary diagnosis of diabetes and identify patients at risk of diabetes.

LH Rapid Quantitative Test (Chemiluminescence Immunoassay)

LH Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Luteinizing hormone (LH) concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.

E2 Rapid Quantitative Test (Chemiluminescence Immunoassay)

E2 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Estradiol (E2) concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants and samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.

PGII Rapid Quantitative Test

Human Pepsinogens are aspartic proteases produced in the gastric mucosa and secreted into the gastric lumen that play a major role in the digestion of proteins after activation of acidic pH. It is synthesized as isoymogens and is classified into two groups (Pepsinogen I and Pepsinogen II).